Literature DB >> 9271756

The natural history of thoracic aortic aneurysm disease: an overview.

M P Pitt1, R S Bonser.   

Abstract

Relatively little is known of the natural history of thoracic aortic aneurysms (TAA). The limited data available suggests that survival is at best equivalent to that observed for abdominal aortic aneurysm (AAA), and probably significantly worse. Patients with an AAA > 6 cm diameter have a 5-year survival of 10%, with a cumulative risk of rupture over 10 years of 43%. Rupture is also responsible for death in 25% of patients with 4-7 cm AAA. Natural history studies of TAA report a 1- and 5-year survival of 39%-52% and 13%-19%, respectively, but many studies include data on acute type A dissection. Although most mortality in patients with TAA is related to aneurysm rupture, data on the relationship between aneurysm size and rupture risk remains scarce. TAA is a highly lethal condition warranting consideration of elective, prophylactic surgical repair. However, the timing of surgery is often a difficult clinical decision, particularly in asymptomatic patients or those with comorbid conditions. Surgery for TAA carries a significant mortality and potentially permanently crippling morbidity. A recommendation of surgery represents a balance, weighing estimates of TAA natural history and rupture risk against operative mortality and complication rate, while carefully considering the impact of important comorbid conditions, e.g., ischemic heart disease, obstructive pulmonary disease, and renal dysfunction. When to intervene is a critical question facing cardiovascular surgeons and is based upon an assessment of the risk of rupture. This risk is related to the site, aetiology, size, and expansion rate of the aneurysm.

Entities:  

Mesh:

Year:  1997        PMID: 9271756

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  9 in total

1.  Acute Type A Aortic Dissection Missed as Acute Coronary Syndrome.

Authors:  Mohammad Mostafa Ansari-Ramandi; Mohammad Javad Alemzadeh-Ansari; Ata Firoozi
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Fatal aortic dissection in a 37-year-old man: missed opportunity.

Authors:  Leah Abitbol; Anthony D'Urzo
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

3.  Surgical treatment for a ruptured thoracic aortic aneurysm.

Authors:  H Shimizu; T Ueda; I Kashima; A Mitsumaru; K Tsutsumi; C Enoki; Y Iino; K Koizumi; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

4.  Clinical and patho-anatomical factors affecting expansion of thoracic aortic aneurysms.

Authors:  R S Bonser; D Pagano; M E Lewis; S J Rooney; P Guest; P Davies; I Shimada
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

5.  Characterization of SMAD2 Activation in Human Thoracic Aortic Aneurysm.

Authors:  Hayato Fukuda; Hiroki Aoki; Shohei Yoshida; Satoru Tobinaga; Hiroyuki Otsuka; Takahiro Shojima; Kazuyoshi Takagi; Yoshihiro Fukumoto; Hidetoshi Akashi; Seiya Kato; Hiroyuki Tanaka
Journal:  Ann Vasc Dis       Date:  2018-03-25

Review 6.  Structural modelling of the cardiovascular system.

Authors:  Benjamin Owen; Nicholas Bojdo; Andrey Jivkov; Bernard Keavney; Alistair Revell
Journal:  Biomech Model Mechanobiol       Date:  2018-06-18

7.  Acute type a aortic dissection in a 36-week pregnant patient.

Authors:  Erol Kohli; Sharhabeel Jwayyed; Gary Giorgio; Mary Colleen Bhalla
Journal:  Case Rep Emerg Med       Date:  2013-05-28

8.  Retrograde type a dissection in a 24th gestational week pregnant patient - the importance of interdisciplinary interaction to a successful outcome.

Authors:  Jerry Easo; Michael Horst; Bernhard Schmuck; Rohit Philip Thomas; Steffen Saupe; Malte Book; Alexander Weymann
Journal:  J Cardiothorac Surg       Date:  2018-05-02       Impact factor: 1.637

9.  Clinical analysis of redo aortic root replacement after cardiac surgery: a retrospective study.

Authors:  Jianying Deng; Qianjin Zhong
Journal:  J Cardiothorac Surg       Date:  2021-07-28       Impact factor: 1.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.